Hammann A - Search Results

1

Involvement of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells.

Droin N, Bichat F, Rébé C, Wotawa A, Sordet O, Hammann A, Bertrand R, Solary E. Droin N, et al. Among authors: hammann a. Blood. 2001 Mar 15;97(6):1835-44. doi: 10.1182/blood.v97.6.1835. Blood. 2001. PMID: 11238127 Free article.

2

Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity.

Micheau O, Solary E, Hammann A, Martin F, Dimanche-Boitrel MT. Micheau O, et al. Among authors: hammann a. J Natl Cancer Inst. 1997 Jun 4;89(11):783-9. doi: 10.1093/jnci/89.11.783. J Natl Cancer Inst. 1997. PMID: 9182976

3

Contribution of the cyclin-dependent kinase inhibitor p27KIP1 to the confluence-dependent resistance of HT29 human colon carcinoma cells.

Dimanche-Boitrel MT, Micheau O, Hammann A, Haugg M, Eymin B, Chauffert B, Solary E. Dimanche-Boitrel MT, et al. Among authors: hammann a. Int J Cancer. 1998 Aug 31;77(5):796-802. doi: 10.1002/(sici)1097-0215(19980831)77:5<796::aid-ijc20>3.0.co;2-z. Int J Cancer. 1998. PMID: 9688315

4

Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs.

Micheau O, Solary E, Hammann A, Dimanche-Boitrel MT. Micheau O, et al. Among authors: hammann a. J Biol Chem. 1999 Mar 19;274(12):7987-92. doi: 10.1074/jbc.274.12.7987. J Biol Chem. 1999. PMID: 10075697 Free article.

5

STAT-1-independent upregulation of FADD and procaspase-3 and -8 in cancer cells treated with cytotoxic drugs.

Micheau O, Hammann A, Solary E, Dimanche-Boitrel MT. Micheau O, et al. Among authors: hammann a. Biochem Biophys Res Commun. 1999 Mar 24;256(3):603-7. doi: 10.1006/bbrc.1999.0391. Biochem Biophys Res Commun. 1999. PMID: 10080945

6

HSP27 inhibits cytochrome c-dependent activation of procaspase-9.

Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, Solary E. Garrido C, et al. Among authors: hammann a. FASEB J. 1999 Nov;13(14):2061-70. doi: 10.1096/fasebj.13.14.2061. FASEB J. 1999. PMID: 10544189

7

Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway.

Favre-Felix N, Fromentin A, Hammann A, Solary E, Martin F, Bonnotte B. Favre-Felix N, et al. Among authors: hammann a. J Immunol. 2000 May 15;164(10):5023-7. doi: 10.4049/jimmunol.164.10.5023. J Immunol. 2000. PMID: 10799856

8

P27KiP1 overexpression inhibits the growth and doxorubicin sensitivity of HT29 human colon cancer cells in vivo.

Dimanche-Boitrel MT, Micheau O, France D, Hammann A, Duchamp O, Genne P, Solary E. Dimanche-Boitrel MT, et al. Among authors: hammann a. Anticancer Res. 2000 Mar-Apr;20(2A):849-52. Anticancer Res. 2000. PMID: 10810365

9

Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.

Lacour S, Hammann A, Wotawa A, Corcos L, Solary E, Dimanche-Boitrel MT. Lacour S, et al. Among authors: hammann a. Cancer Res. 2001 Feb 15;61(4):1645-51. Cancer Res. 2001. PMID: 11245478

10

Modulation of apoptosis by procaspase-2 short isoform: selective inhibition of chromatin condensation, apoptotic body formation and phosphatidylserine externalization.

Droin N, Rébé C, Bichat F, Hammann A, Bertrand R, Solary E. Droin N, et al. Among authors: hammann a. Oncogene. 2001 Jan 11;20(2):260-9. doi: 10.1038/sj.onc.1204066. Oncogene. 2001. PMID: 11313953

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters